CORCEPT THERAPEUTICS INC (CORT) › Capital ExpendituresCORCEPT THERAPEUTICS INC (CORT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $25.0K2012: $151.0K2013: $127.0K2014: $174.0K2015: $17.0K2016: $194.0K2017: $419.0K2018: $298.0K2019: $1.09M2020: $1.24M2021: $469.0K2022: $413.0K2023: $139.0K2024: $2.17M2025: $211.0K$211.0K2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$211.0K-90.3%2024$2.17M+1462.6%2023$139.0K-66.3%2022$413.0K-11.9%2021$469.0K-62.1%2020$1.24M+13.8%2019$1.09M+265.1%2018$298.0K-28.9%2017$419.0K+116.0%2016$194.0K+1041.2%2015$17.0K-90.2%2014$174.0K+37.0%2013$127.0K-15.9%2012$151.0K+504.0%2011$25.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share